4,088 Shares in DaVita Inc. (NYSE:DVA) Purchased by Roberts Capital Advisors LLC

Key Points

• Roberts Capital Advisors LLC acquired 4,088 shares of DaVita Inc. (NYSE:DVA), worth approximately $625,000, in the first quarter of 2023.
• Insider James O. Hearty sold 2,351 shares at an average price of $150.00, reducing his stake in the company by 8.28%.
• DaVita reported $2.95 earnings per share for the latest quarter, surpassing analysts' expectations of $2.70, and achieved a 6.1% year-over-year revenue growth.

Roberts Capital Advisors LLC acquired a new position in DaVita Inc. (NYSE:DVA - Free Report) during the 1st quarter, according to its most recent filing with the SEC. The fund acquired 4,088 shares of the company's stock, valued at approximately $625,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. United Capital Financial Advisors LLC raised its stake in DaVita by 2.6% in the 4th quarter. United Capital Financial Advisors LLC now owns 2,416 shares of the company's stock valued at $361,000 after purchasing an additional 62 shares during the last quarter. Freedom Investment Management Inc. increased its stake in shares of DaVita by 3.6% during the 4th quarter. Freedom Investment Management Inc. now owns 1,790 shares of the company's stock valued at $268,000 after acquiring an additional 62 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in shares of DaVita by 2.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,551 shares of the company's stock valued at $531,000 after acquiring an additional 69 shares during the last quarter. UMB Bank n.a. increased its stake in shares of DaVita by 65.5% during the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock valued at $29,000 after acquiring an additional 76 shares during the last quarter. Finally, Exchange Traded Concepts LLC increased its stake in shares of DaVita by 8.9% during the 1st quarter. Exchange Traded Concepts LLC now owns 970 shares of the company's stock valued at $148,000 after acquiring an additional 79 shares during the last quarter. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have recently commented on DVA. Truist Financial set a $148.00 price objective on shares of DaVita in a research note on Friday, August 8th. Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a research note on Friday, April 25th. Finally, Barclays dropped their price objective on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a research note on Thursday, August 7th.

Insider Activity

In other DaVita news, insider James O. Hearty sold 2,351 shares of the company's stock in a transaction that occurred on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the transaction, the insider owned 26,038 shares in the company, valued at $3,905,700. This represents a 8.28% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.50% of the company's stock.

DaVita Stock Up 0.7%

Shares of NYSE:DVA opened at $135.35 on Friday. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.34 and a current ratio of 1.39. DaVita Inc. has a 1 year low of $126.07 and a 1 year high of $179.60. The stock has a market capitalization of $9.68 billion, a P/E ratio of 13.31, a PEG ratio of 0.96 and a beta of 1.09. The stock has a 50-day simple moving average of $139.68 and a 200-day simple moving average of $145.47.

DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.70 by $0.25. DaVita had a return on equity of 369.39% and a net margin of 6.35%. The business had revenue of $3.38 billion during the quarter, compared to analysts' expectations of $3.36 billion. During the same quarter in the previous year, the business earned $2.00 EPS. The company's revenue for the quarter was up 6.1% on a year-over-year basis. Equities analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.